IGF2BP3 and astrocytoma (excluding glioblastoma): Dutoit et al. also showed overexpression of IGF2BP3 in astrocytomas and GBMs27 and that its expression level was increased in six of seven recurrent secondary GBMs that progressed from grade II or III astrocytomas.